Choice of supraglottic airway devices: a network meta-analysis of randomised controlled trials
British Journal of Anaesthesia · 2024-12 · 133 (6) · 1284-1306
DOI: 10.1016/j.bja.2024.09.001 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift British Journal of Anaesthesia, 2024-12. Verfasst von Muthuraj Kanakaraj und 6 weiteren Autor:innen. Beteiligte Einrichtung: Washington University in Saint Louis, Anaesthesiology Barnes Jewish Hospital, Saint Louis, MO, USA. Hauptthemen laut MEDLINE: Laryngeal Masks, Randomized Controlled Trials as Topic, Airway Management. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 145 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND: Over the last two decades, significant research interest has led to the development of a wide variety of supraglottic airways (SGAs) for anaesthesia providers to choose from. METHODS: In this network meta-analysis, we analysed 111 studies, enrolling 12 045 patients undergoing airway management with 29 SGAs. We targeted outcomes that contribute to clinicians' choice of one SGA over another. The primary outcome was the incidence of postoperative sore throat (POST). Secondary outcomes were first-attempt insertion success, bleeding complications, and oropharyngeal leak pressure (OLP). Based on credible intervals, we created a 'rank order' to guide decision-making for clinicians. RESULTS: The highest-ranking devices based on credible intervals for POST, bleeding complications, first-attempt insertion success, and OLP were LMA Ambu, Jcerity Endoscoper, LMA Blockbuster, and LMA Baska Mask, respectively. Air-Q and i-gel ranked favourably across multiple outcomes, with i-gel being the only device to rank within the top six SGAs for POST, bleeding, and first-attempt success despite ranking poorly for OLP. CONCLUSIONS: Our data support the use of LMA-Ambu, Jcerity-Endoscoper, Air-Q, and i-gel when considering patient-centred outcomes. Clinician familiarity with these devices and their continued expansion into anaesthetic practice will have important implications on the perioperative patient experience. SYSTEMATIC REVIEW PROTOCOL: PROSPERO (CRD42022383136).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Washington University in Saint Louis, Anaesthesiology Barnes Jewish Hospital, Saint Louis, MO, USA.
- Department of Anaesthesiology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
- Department of Anesthesiology, Mount Sinai Hospital, Toronto, ON, Canada.
- Department of Anesthesiology, St Elizbeth's Medical Center, Boston University School of Medicine, Boston, MA, USA.
- Department of Biological Sciences, Washington University School of Medicine in St. Louis, MO, USA.
- Washington University in Saint Louis, Anaesthesiology Barnes Jewish Hospital, Saint Louis, MO, USA. Electronic address: singh.p@wustl.ed.
Zitieren
APA
Kanakaraj, M., Bhat, A. D., Singh, N. P., Balasubramanian, S., Tyagi, A., Aathreya, R., & Singh, P. M. (2024). Choice of supraglottic airway devices: a network meta-analysis of randomised controlled trials. British Journal of Anaesthesia, 133(6), 1284-1306. https://doi.org/10.1016/j.bja.2024.09.001
Vancouver
Kanakaraj M, Bhat AD, Singh NP, Balasubramanian S, Tyagi A, Aathreya R, et al. Choice of supraglottic airway devices: a network meta-analysis of randomised controlled trials. British Journal of Anaesthesia. 2024;133(6):1284-1306. doi:10.1016/j.bja.2024.09.001
BibTeX
@article{Kanakaraj2024,
author = {Kanakaraj, Muthuraj and Bhat, Adithya D and Singh, Narinder P and Balasubramanian, Sennaraj and Tyagi, Abhay and Aathreya, Rohan and Singh, Preet M},
title = {Choice of supraglottic airway devices: a network meta-analysis of randomised controlled trials},
journal = {British Journal of Anaesthesia},
year = {2024},
volume = {133},
number = {6},
pages = {1284--1306},
doi = {10.1016/j.bja.2024.09.001}
}
EUVIMED